MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.diabres.2023.110865

Медицинская библиотека · Diabetes research and clinical practice · 2023

Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial.

Petersen Erika A, Stauss Thomas G, Scowcroft James A, Jaasma Michael J, Brooks Elizabeth S, Edgar Deborah R, White Judith L, Sills Shawn M, Amirdelfan Kasra, Guirguis Maged N, Xu Jijun, Yu Cong, Nairizi Ali, Patterson Denis G, Tsoulfas Kostandinos C, Creamer Michael J, Galan Vincent, Bundschu Richard H, Mehta Neel D, Sayed Dawood, Lad Shivanand P, DiBenedetto David J, Sethi Khalid A, Goree Johnathan H, Bennett Matthew T, Harrison Nathan J, Israel Atef F, Chang Paul, Wu Paul W, Argoff Charles E, Nasr Christian E, Taylor Rod S, Caraway David L, Mekhail Nagy A

Рандомизированное исследованиеМногоцентровое исследованиеСтатьяПеревод в очереди

Аннотация

AIMS: To evaluate the long-term efficacy of high-frequency (10 kHz) spinal cord stimulation (SCS) for treating refractory painful diabetic neuropathy (PDN).

METHODS

The SENZA-PDN study was a prospective, multicenter, randomized controlled trial that compared conventional medical management (CMM) alone with 10 kHz SCS plus CMM (10 kHz SCS+CMM) in 216 patients with refractory PDN. After 6 months, participants with insufficient pain relief could cross over to the other treatment. In total, 142 patients with a 10 kHz SCS system were followed for 24 months, including 84 initial 10 kHz SCS+CMM recipients and 58 crossovers from CMM alone. Assessments included pain intensity, health-related quality of life (HRQoL), sleep, and neurological function. Investigators assessed neurological function via sensory, reflex, and motor tests. They identified a clinically meaningful improvement relative to the baseline assessment if there was a significant persistent improvement in neurological function that impacted the participant's well-being and was attributable to a neurological finding.

RESULTS

At 24 months, 10 kHz SCS reduced pain by a mean of 79.9% compared to baseline, with 90.1% of participants experiencing ≥50% pain relief. Participants had significantly improved HRQoL and sleep, and 65.7% demonstrated clinically meaningful neurological improvement. Five (3.2%) SCS systems were explanted due to infection.

CONCLUSIONS

Over 24 months, 10 kHz SCS provided durable pain relief and significant improvements in HRQoL and sleep. Furthermore, the majority of participants demonstrated neurological improvement. These long-term data support 10 kHz SCS as a safe and highly effective therapy for PDN.

TRIAL REGISTRATION: ClincalTrials.gov Identifier, NCT03228420.

Для цитирования: Petersen Erika A, Stauss Thomas G, Scowcroft James A, Jaasma Michael J, Brooks Elizabeth S, Edgar Deborah R, White Judith L, Sills Shawn M, Amirdelfan Kasra, Guirguis Maged N, Xu Jijun, Yu Cong, Nairizi Ali, Patterson Denis G, Tsoulfas Kostandinos C, Creamer Michael J, Galan Vincent, Bundschu Richard H, Mehta Neel D, Sayed Dawood, Lad Shivanand P, DiBenedetto David J, Sethi Khalid A, Goree Johnathan H, Bennett Matthew T, Harrison Nathan J, Israel Atef F, Chang Paul, Wu Paul W, Argoff Charles E, Nasr Christian E, Taylor Rod S, Caraway David L, Mekhail Nagy A. Long-term efficacy of high-frequency (10 kHz) spinal cord stimulation for the treatment of painful diabetic neuropathy: 24-Month results of a randomized controlled trial.. Diabetes research and clinical practice. 2023. DOI: 10.1016/j.diabres.2023.110865.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.